Literature DB >> 7580017

The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): what is the optimal dose?

M H van Hooff1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7580017     DOI： 10.1007/BF02212923

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN： 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  12 in total

1.  The predictive value and the management of cycles with low initial estradiol levels.

Authors:  A Hershlag; M C Asis; M P Diamond; A H DeCherney; G Lavy
Journal:  Fertil Steril       Date:  1990-06       Impact factor: 7.329

2.  High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients.

Authors:  V C Karande; G S Jones; L L Veeck; S J Muasher
Journal:  Fertil Steril       Date:  1990-03       Impact factor: 7.329

3.  Increasing the human menopausal gonadotropin dose--does the response really improve?

Authors:  C Pantos; S J Thornton; A L Speirs; I Johnston
Journal:  Fertil Steril       Date:  1990-03       Impact factor: 7.329

4.  High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer.

Authors:  L Stadtmauer; E C Ditkoff; D Session; A Kelly
Journal:  Fertil Steril       Date:  1994-06       Impact factor: 7.329

Review 5.  The FSH threshold concept in clinical ovulation induction.

Authors:  J Schoemaker; M M van Weissenbruch; F Scheele; M van der Meer
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1993-06

6.  Ovarian response of individuals to different doses of human menopausal gonadotropin.

Authors:  C A Benadiva; Z Ben-Rafael; J F Strauss; L Mastroianni; G L Flickinger
Journal:  Fertil Steril       Date:  1988-06       Impact factor: 7.329

7.  Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study.

Authors:  M H van Hooff; A T Alberda; G J Huisman; G H Zeilmaker; R A Leerentveld
Journal:  Hum Reprod       Date:  1993-03       Impact factor: 6.918

8.  Increased human menopausal gonadotropin dose during the early follicular phase: effect on follicular recruitment and treatment outcome.

Authors:  J Blankstein; R L Collins; K A Easley; M M Quigley
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-04

9.  Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels.

Authors:  Z Ben-Rafael; S Lipitz; D Bider; S Mashiach
Journal:  Fertil Steril       Date:  1991-02       Impact factor: 7.329

10.  Lower doses of human menopausal gonadotropin are associated with improved success with in vitro fertilization in women with low body weight.

Authors:  J Halme; M G Hammond; L Bailey; L M Talbert
Journal:  Am J Obstet Gynecol       Date:  1988-01       Impact factor: 8.661
View more
  1 in total

1.  The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer.

Authors:  Xiao-Jin Zhang; Su-Ying Liu; Wei Fu; Xiao-Xi Sun
Journal:  Reprod Biol Endocrinol       Date:  2015-10-06       Impact factor: 5.211
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.